Organization
Xuanwu Hospital
19 clinical trials
1 abstract
Clinical trial
The Effect of Exosomes Derived From Human Induced Pluripotent Stem Cell (GD-iExo-003) in Acute Ischemic Stroke: an Exploratory Study.Status: Recruiting, Estimated PCD: 2025-08-30
Abstract
Neoadjuvant long-course chemoradiation plus PD1 blockade for locally advanced rectal cancer: Results of a phase 2, open-label, randomized controlled trial.Org: Beijing Friendship Hospital, Xuanwu Hospital, Beijing Chaoyang Hospital, Beijing Hospital,
Clinical trial
The Effect of Betaine in Refractory Syringomyelia（RS）Status: Recruiting, Estimated PCD: 2027-03-01
Clinical trial
Prehabilitation Combined With Enhanced Recovery After Surgery (PREERAS) in the Chinese Elderly With Spine SurgeryStatus: Recruiting, Estimated PCD: 2025-12-30
Clinical trial
A Single-arm Phase 2 Study of Apatinib (Anti-PD-1) Combined With Camrelizumab (Anti-VEGFR ) in Patients With Advanced ChordomaStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Dimethyl Fumarate for the Treatment of Intracerebral HemorrhageStatus: Withdrawn, Estimated PCD: 2021-12-31
Clinical trial
Effects of Medical Treatment of Intracranial Atherosclerotic Diseases Based on Magnetic Resonance Fractional Flow ReserveStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Impact of an Immune Modulator Dimethyl Fumarate on Acute Ischemic StrokeStatus: Terminated, Estimated PCD: 2023-02-08
Clinical trial
Combination of the Immune Modulator Dimethyl Fumarate With Intraarterial Treatment in Acute Ischemic StrokeStatus: Withdrawn, Estimated PCD: 2021-12-31
Clinical trial
Efficacy and Safety of Steroid for Treatment of Acute/Subacute Severe Cerebral Venous Thrombosis.Status: Completed, Estimated PCD: 2021-12-31
Clinical trial
Intra-arterial Thrombolysis After Successful Thrombectomy for Acute Ischemic Stroke Due to Large Vessel Occlusion in the Posterior Circulation (IAT-TOP)Status: Recruiting, Estimated PCD: 2025-07-01
Clinical trial
Effectiveness and Safety of Edaravone Dexborneol in Acute Ischemic Stroke: a Multicenter, Prospective, Patient-centered, Real-world Cohort StudyStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Effectiveness and Safety of Inebilizumab in the Acute Phase of Neuromyelitis Optica Spectrum Disorders-a Multicentric, Prospective, Real Word StudyStatus: Not yet recruiting, Estimated PCD: 2025-07-31
Clinical trial
Intravenous Thrombolysis With Recombinant Human TNK Tissue-type Plasminogen Activator (rhTNK-tPA) for Acute Non-large Vessel Occlusion in Extended Time Window--A Multicenter, Prospective, Randomized, Open-label, Blinded End-point TrialStatus: Recruiting, Estimated PCD: 2024-06-30
Clinical trial
Safety and Efficacy of Autologous Induced Neural Stem Cell-derived Dopaminergic Precursor Cells in the Treatment of Parkinson's DiseaseStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Carotid Revascularization Versus Best Medical Treatment for Asymptomatic Carotid Stenosis: a Multicenter, Open, Randomized Controlled Trial in Chinese PopulationStatus: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
The Effect of Thalidomide in Refractory Syringomyelia（RS）: a Phase II Clinical TrialStatus: Recruiting, Estimated PCD: 2027-02-01
Clinical trial
A Phase II Exploratory Clinical Study Investigating the Geroprotective Effect of Metformin in Middle-aged and Elderly PeopleStatus: Not yet recruiting, Estimated PCD: 2026-09-30
Clinical trial
An Exploratory Study on the Safety and Efficacy of Universal CAR-T Cells Targeting BCMA and CD19 in the Treatment of Refractory Autoimmune Diseases of the Nervous SystemStatus: Not yet recruiting, Estimated PCD: 2026-12-31